Your browser doesn't support javascript.
loading
Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction.
Oshiro, Satoshi; Tada, Tatsuya; Mizutani, Naeko; Funatogawa, Keiji; Sekiguchi, Jun-Ichiro; Takahashi, Masao; Kirikae, Teruo.
Afiliación
  • Oshiro S; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
  • Tada T; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
  • Mizutani N; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
  • Funatogawa K; Tochigi Prefectural Institute of Public Health and Environmental Science, Utsunomiya, Tochigi, Japan.
  • Sekiguchi JI; Microbiology Research Division, Kohjin Bio Co., Ltd., Saitama, Japan.
  • Takahashi M; Aotearoa Co., Ltd., Tokyo, Japan.
  • Kirikae T; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
Int Dairy J ; 117: 105002, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33526960
Bovine whey IgG enriched fraction contains antibodies against various human bacterial pathogens. It contains antibodies against some viral antigens, including human respiratory syncytial virus and influenza virus. We investigated whether the IgG enriched fraction has cross-reactivity with IgG antibodies against SARS-CoV-2 spike (S) and nucleocapsid (N) proteins. The full-length and partial-length SARS-CoV-2 S, N, a recombinant protein of the receptor binding domain (RBD) and nine peptides covering the receptor binding motif (RBM) of S were prepared. Direct enzyme-linked immunosorbent assays were conducted using these recombinant proteins and peptides as coating antigens and revealed the IgG enriched fraction contained antibodies against partial-length S [amino acids (aa) 177-512, 288-512, 348-578, 387-516 and 408-664], full-length N (aa 1-419) and partial-length N (aa 1-120, 111-220, 1-220 and 210-419), two RBD peptides, covering aa 427-446 and 502-520 of S, and recombinant RBD of S. These results indicate IgG enriched fraction contains antibodies against SARS-CoV-2.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Int Dairy J Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Int Dairy J Año: 2021 Tipo del documento: Article País de afiliación: Japón